See All Slides - tctmd.com

Slides

Presentation TCT 2012

Dedicated Bifurcation Stents: Cappella Program Update

Presenter: Fernando Cura

October 22, 2012

Presentation TCT 2012

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Presentation TCT 2012

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

Presenter: Huay Cheem Tan

October 22, 2012

Presentation TCT 2012

AND, Should Also be Based on Hemodynamic Assessments: The Dimensionless AR Index

Presenter: Georg Nickenig

October 22, 2012

Presentation TCT 2012

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Presenter: David Cormode

October 22, 2012

Presentation TCT 2012

TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement

Presenter: Nicolo Piazza

October 22, 2012

Presentation TCT 2012

Uses and Utility of IVUS During Bifurcation Stenting

Presenter: Akiko Maehara

October 22, 2012

Presentation TCT 2012

Case 2: PCI in STEMI

Presenter: Vladimir Ganyukov

October 22, 2012

Presentation TCT 2012

Precise Trial Results: Adipose Derived Cells for CMI

Presenter: Francisco Fernandez-Aviles

October 22, 2012

Advertisement

Slides

Dedicated Bifurcation Stents: Cappella Program Update

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

AND, Should Also be Based on Hemodynamic Assessments: The Dimensionless AR Index

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

TAVR Use Patterns on the European Continent: Growth, Penetration, and Reimbursement

Uses and Utility of IVUS During Bifurcation Stenting

Case 2: PCI in STEMI

Precise Trial Results: Adipose Derived Cells for CMI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content